About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: Advisory Committee Prepapartion
“Can You Hear Me?” – The (Hopefully) Coming Transition from Virtual Meetings
Today, FDA published notice in the Federal Register of an upcoming meeting of the Arthritis Drugs Advisory Committee that will be held May 6. The meeting will be held virtually. Last year when the pandemic reality started setting in, like … Continue reading
Posted in Advisory Committee Prepapartion, Current Affairs
Tagged #AdCom, #AdComm, COVID19
Comments Off on “Can You Hear Me?” – The (Hopefully) Coming Transition from Virtual Meetings
Approvals in the Crazy Year of 2020
Each year in January, it is relevant to look back on the activities of FDA during the course of the previous year and look at how it was the same or different from prior years, and to look at trends … Continue reading
Posted in Advisory Committee Prepapartion, FDA Image, FDA Policy
Tagged #pharma, Drug Approvals
Comments Off on Approvals in the Crazy Year of 2020
FDA AdComm Agenda Covers the Bases
First of all, we are having a bit of a crisis with our crisis. As we appear to be moving into yet another wave of COVID-19 infections, and as research into a vaccine is aggressively underway, we also see serious … Continue reading
Posted in Advisory Committee Prepapartion, COVID19, Current Affairs, FDA Image, FDA Policy
Tagged #COVID19
Comments Off on FDA AdComm Agenda Covers the Bases
FDA to Hold Virtual AdComm
I don’t usually publish the scheduling of an AdComm with a blog posting. But this one merits one. With fewer than the usual minimum of fifteen days’ notice, FDA has scheduled an FDA Advisory Committee meeting of the Cardiovascular and … Continue reading
Posted in Advisory Committee Prepapartion, FDA Image, FDA Policy
Tagged #AdCom, #AdComm, #FDAAdvisoryCommittee
Comments Off on FDA to Hold Virtual AdComm
Principles for COVID-19 Healthcare Communications – 2 – The Virtual Medical Meeting
Virtually everyone is going virtual. Even in February, which seems like a very long time ago, many organizers began either postponing or canceling major conferences and meetings. This has included major medical meetings and given that large gatherings will be … Continue reading
Posted in Advisory Committee Prepapartion, Current Affairs
Comments Off on Principles for COVID-19 Healthcare Communications – 2 – The Virtual Medical Meeting